March 31, 2017
The Future of Medicare Advantage
February 27, 2017
The 2016 Election: How Will It Affect the US Health Care Industry?
October 20, 2016
Future Scenarios for US Physician Practice Under MACRA
September 8, 2016
Outcome-Based Contracts for Pharmaceutical Products: Opportunities and Challenges
March 17, 2016
Home-Based Healthcare in the 21st Century
November 9, 2015
Healthcare Consolidation: Winners, Losers and Policy Implications
June 9, 2015
The Future of Pharmaceutical Benefit Management
May 12, 2015
The 22nd Princeton Conference, Challenges Facing the US Health Care System
April 2, 2015
Comprehensive Health Care Payment Reform: What Will it Take to Get There?
January 21, 2015
The Recent Deceleration in Health Spending: Is it for Real?
October 30, 2014
Tiered and Limited Network Health Insurance Plans: Balancing Access And Affordability
June 3, 2014
The Evolution of Accountable Care Under Medicare
May 13, 2014
Princeton Conference XXI The Changing Health Care Landscape
March 18, 2014
The Future of Post-Acute Care Under Value-Based Payment
January 28, 2014
What's Next for the CMS Innovation Center?
October 31, 2013
Designing Affordable Health Insurance Products: The Role of Purchasers, Payers, Providers and Policy
June 25, 2013
Purchasing Decisions in an Accountable-Care World: How Will Provider Groups Define Value?
May 22, 2013
20th Princeton Conference: The U.S. Health Care System in Transition
March 11, 2013
The Future of the American Hospital
January 10, 2013
Post-Election Outlook for the Health Care Industry
October 22, 2012
Building the Components of Accountable Care: What Do Physicians, Hospitals and Insurers Need to Do Differently?
July 24, 2012
Molecular Diagnostics and Companion Therapies: Partnerships, Payment and Evidence Development
May 23, 2012
States’ Role in Health Care Reform: Possibilities to Improve Access and Quality
April 5, 2012
Reducing Waste in the US Health Care System: Addressing Political and Technical Barriers
November 8, 2011
How Will Deficit Reduction Impact the Health Care System?
October 19, 2011
Advancing Comparative Effectiveness Research under Health Care Reform
July 13, 2011
The Evolution of State Health Insurance Exchanges
May 23, 2011
Where Do We Go From Here? The Future of Health Reform
May 17, 2011
Episode Payment: Private Innovation and Opportunities for Medicare - Special Meeting on Episode Payment Features with CMMI Chief Rick Gilfillan
March 30, 2011
ACO Development: Policy meets Reality
February 4, 2011
Accelerating Innovation in Health Care Payment and Delivery: A Conversation with CMMI Chief Rick Gilfillan
October 14, 2010
Accountable Care Organizations: Implications for Consumers
September 20, 2010
Strategies for Optimizing Secondary Use of Data Through Health Information Exchange
August 5, 2010
Advancing Electronic Health Records Adoption and Meaningful Use
July 8, 2010
How Can the Private Sector Advance Meaningful Use?
June 24, 2010
Shaping Convergent Strategies in Comparative Effectiveness Research
May 19, 2010
The 17th Princeton Conference
April 16, 2010
Building Accountable Care Organizations
January 14, 2010
Jump-Starting the Medicare Innovation Center
October 14, 2009
Accelerating High-Value Healthcare
September 16, 2009
Next Steps Toward a Robust Comparative Effectiveness Research Enterprise
July 20, 2009
Establishing a National Health Insurance Exchange
June 11, 2009
Federal Strategies for Promoting Affordable Biologics: Follow-On Biologic Competition
April 29, 2009
Implementing Bundled Payments for Health Care Services
November 24, 2008
Medicare Delivery System Reform
October 2, 2008
Specialty Pharmaceuticals: Policy Solutions for Encouraging Access and Affordability
July 16, 2008
Managing Specialty Pharmaceuticals
June 4, 2008
"Road Testing" Electronic Medical Records
April 30, 2008
April 10, 2008
Payment and Delivery System Reform
November 29, 2007
Comparative Effectiveness Congressional Briefing
November 27, 2007
Overview of Cost Management Strategies
October 24, 2007
Coverage With Evidence Development
October 2, 2007
Value-Based Payment for Medical Technologies
September 18, 2007
Personalized Medicine Conference
July 25, 2007
Comparative Effectiveness: Stakeholder Perspectives
April 11, 2007
Post Marketing Surveillance
February 14, 2007
Comparative Effectiveness Research: Congressional Briefing
November 30, 2006
Comparative Effectiveness Forum
October 12, 2006
Coverage Policy in an Era of Personalized Medicine
July 13, 2006
Pharmaceutical Benefit Management
May 1, 2006
April 4, 2006
October 3, 2005
Promoting Appropriate Utilization
April 1, 2005
Evidence-Based Health Care System
July 16, 2004
Correcting Underuse in Health Care
May 12, 2015
The 22nd Princeton Conference, Challenges Facing the US Health Care System
Co-Sponsored by The Massachusetts Health Policy Forum
THE IMPACT OF CONSOLIDATION IN THE HEALTH CARE DELIVERY AND FINANCING SYSTEMS
This session will examine the recent trends in and effects of consolidation among organizations in the US health care system. Speakers will address overall rise in these kinds of transactions as well as regional differences in consolidation across markets. Session presentations and discussions will seek to discuss the implications of this consolidation. Does consolidation improve quality and care efficiency? Are the results of consolidation detrimental to competition and service pricing? The panel will also discuss responses of regulators and industry players to mergers and acquisitions, exploring market and regulatory approaches to limiting or facilitating them.
HOW DO WE GET A HEALTH CARE WORKFORCE FOR THE 21ST CENTURY?
This session will explore what the health care workforce should look like in the next decade, and the means by which that workforce will be created. Presentations and discussions will examine the cap on residency spots and its effect on the supply of doctors for the health care system. The current status of the new Graduate Nursing Education (GNE) demonstration funded by CMS through the ACA will be highlighted. Additionally, the current state of and potential improvements to graduate medical education (GME) will be discussed. The benefits or detriments of government funding for training will also be explored.
THE SPECIALTY PHARMACEUTICALS MARKETPLACE: IS PRICE INELASTICITY SUSTAINABLE?
The branded pharmaceutical market is rapidly shifting to a novel category of products that treat smaller numbers of patients at tremendous cost. This specialty pharmaceutical market, comprised of orphan drugs and biologics, is poised to grow to 50% of US prescription drug spending by 2019. While there is tremendous interest in the field of personalized medicine enabled by these products, there is an increasing need to assess the seeming price inelastic nature of this market. Is the pricing of these products a bubble or a sustainable transformation of the health care market? This panel will examine the role of specialty pharmaceutical products from the perspectives of investors and purchasers to examine the origins, trends and future of this market.
THE PRIVATE INSURANCE MARKET: THE INFLUENCE OF NEW PAYMENT AND DELIVERY MODELS ON CHANGING PROVIDER PRACTICE PATTERNS AND CONSUMER BEHAVIOR
This session will explore the new payment and delivery models introduced to both employer-financed and exchange markets to improve health outcomes and overall value, as well as to influence provider and consumer decision-making.
THE MAJOR ISSUES AFFECTING MEDICARE GOING FORWARD
What are the major challenges facing the Medicare program in the near future, and where do opportunities for improvement exist? This panel will discuss the development of Medicare ACOs and other policies intended to improve traditional Medicare, the role of private plans in providing Medicare benefits, and other potential reforms to the Medicare program as they relate to the fiscal viability of the program, the quality of care, delivery system reform, and the potential for disruptive innovation.
QUALITY: HAS THE HEALTH CARE SYSTEM MADE SUFFICIENT PROGRESS?
Over the past 15 years, credible research has informed us about the serious lapses in our US health care system in terms of safety, reliability and efficiency. Recent reports document some progress in selected areas but also bring new evidence of overtreatment, persistent errors, waste and preventable hospitalizations. This session asks the fundamental question: have we made enough progress in 15 years to remove waste, lower costs, improve outcomes of care, and prevent injury, infection and unnecessary mortality? If not, what is holding us back? Are we preparing our health care professionals and teams to perform at their highest levels and to produce the best possible outcomes of care? Should we raise the bar for quality patient outcomes, and what it would take to achieve system-wide quality improvement? Panelists will explore recent efforts to create better quality and discuss whether the system has achieved a sufficient capacity for change.
THE POLITICAL SCENE
This panel will incorporate varied perspectives to address the political, legislative, and legal aspects of health care reform and implementation. Topics to be addressed include the implications of the Medicare Sustainable Growth Rate (SGR) bill as well as the Supreme Court's decision in the King v. Burwell challenge to the Affordable Care Act (ACA). Panelists will also discuss facets of ACA implementation and the upcoming issues which will be faced with managing and funding public programs.